These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11817990)

  • 1. Onychomycosis: health-related quality of life considerations.
    Shaw JW; Joish VN; Coons SJ
    Pharmacoeconomics; 2002; 20(1):23-36. PubMed ID: 11817990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis.
    Potter LP; Mathias SD; Raut M; Kianifard F; Tavakkol A
    Health Qual Life Outcomes; 2006 Aug; 4():50. PubMed ID: 16911778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A health-related quality of life measure for use in patients with onychomycosis: a validation study.
    Lubeck DP; Gause D; Schein JR; Prebil LE; Potter LP
    Qual Life Res; 1999; 8(1-2):121-9. PubMed ID: 10457745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the impact of onychomycosis on patient quality of life.
    Turner RR; Testa MA
    Qual Life Res; 2000 Feb; 9(1):39-53. PubMed ID: 10981205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NailQoL: a quality-of-life instrument for onychomycosis.
    Warshaw EM; Foster JK; Cham PM; Grill JP; Chen SC
    Int J Dermatol; 2007 Dec; 46(12):1279-86. PubMed ID: 18173524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with toenail onychomycosis.
    Milobratović D; Janković S; Vukičević J; Marinković J; Janković J; Railić Z
    Mycoses; 2013 Sep; 56(5):543-51. PubMed ID: 23496237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of onychomycosis on quality of life.
    Drake LA; Scher RK; Smith EB; Faich GA; Smith SL; Hong JJ; Stiller MJ
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):702-4. PubMed ID: 9591814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative review of generic quality-of-life instruments.
    Coons SJ; Rao S; Keininger DL; Hays RD
    Pharmacoeconomics; 2000 Jan; 17(1):13-35. PubMed ID: 10747763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Reported Outcomes in Onychomycosis: A Review of Psychometrically Evaluated Instruments in Assessing Treatment Effectiveness.
    Wang J; Wiznia LE; Rieder EA
    Skin Appendage Disord; 2017 Aug; 3(3):144-155. PubMed ID: 28879191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring health-related quality of life in patients with progressive supranuclear palsy.
    Schrag A; Selai C; Quinn N; Hobart J
    Neurocase; 2005 Aug; 11(4):246-9. PubMed ID: 16093224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of toenail onychomycosis on patient quality of life.
    Elewski BE
    Int J Dermatol; 1997 Oct; 36(10):754-6. PubMed ID: 9372349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life.
    Drake LA; Patrick DL; Fleckman P; Andr J; Baran R; Haneke E; Sapède C; Tosti A
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):189-96. PubMed ID: 10426887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome tools for diabetes-specific quality of life: Study performed in a private family practice clinic.
    Nair R; Kachan P
    Can Fam Physician; 2017 Jun; 63(6):e310-e315. PubMed ID: 28615409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives.
    Swigris JJ; Stewart AL; Gould MK; Wilson SR
    Health Qual Life Outcomes; 2005 Oct; 3():61. PubMed ID: 16212668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life of persons with onychomycosis.
    Lubeck DP; Patrick DL; McNulty P; Fifer SK; Birnbaum J
    Qual Life Res; 1993 Oct; 2(5):341-8. PubMed ID: 8136799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-specific quality of life assessment in intermittent claudication: review.
    Mehta T; Venkata Subramaniam A; Chetter I; McCollum P
    Eur J Vasc Endovasc Surg; 2003 Mar; 25(3):202-8. PubMed ID: 12623330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring health-related quality of life in older patient populations: a review of current approaches.
    Hickey A; Barker M; McGee H; O'Boyle C
    Pharmacoeconomics; 2005; 23(10):971-93. PubMed ID: 16235972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of fingernail psoriasis on patients' health-related and disease-specific quality of life.
    van der Velden HM; Klaassen KM; van de Kerkhof PC; Pasch MC
    Dermatology; 2014; 229(2):76-82. PubMed ID: 25171519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires.
    Regnault A; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Benmedjahed K; Bosch AM
    Orphanet J Rare Dis; 2015 May; 10():59. PubMed ID: 25958326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring quality of life in paediatric patients.
    Connolly MA; Johnson JA
    Pharmacoeconomics; 1999 Dec; 16(6):605-25. PubMed ID: 10724790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.